DEI

Enhancing diversity, equity and inclusion (DEI) in clinical trial populations is a moral imperative. It has long been acknowledged that DEI is crucial for broadening the scope, creativity and innovativeness of medical research and bolsters success in solving complex problems whilst reducing inequities in health and disease.

Read More

Medical Writing Checklist We, at Inklab Communications, have put together a helpful checklist for medical writers to use in order to hone and add value to a prospective powerpoint slide deck.

Read More

Read In the wake of the 21st Century Cures Act (December 2016), the FDA has determined to accelerate the development of novel therapies and increase the speed of the review process, particularly in the field of cancer research.

Read More

Vaccination is a crucial preventative measure to protect against disease and has helped to eradicate epidemics like smallpox and polio. They enable our bodies to respond more effectively to infection by mimicking the structure of the infectious agent. RNA (sometimes referred to as messenger RNA or mRNA) vaccines, are a new type of vaccine that has recently been developed. They rely on a different way to mimic infection to induce an immune cell response.

Read More

The pressure mounts for publications and medical affairs teams to demonstrate the effectiveness of their activities, and so too does the temptation to stick with traditional metrics of success and the ones that make us look good. However, is that really effective?

Read More